In Regard to Zelefsky et al

In a phase 3 multicenter randomized trial, Zelefsky et al compared 24 Gy single-dose radiation therapy (SDRT) to 27 Gy (3-fraction) stereotactic body radiation therapy in 117 patients experiencing oligometastatic progression in 154 lesions. 1 Zelefsky MJ, Yamada Y, Greco C, Lis E, et al. Phase 3 multi-center, prospective, randomized trial comparing single dose 24 Gy radiotherapy to a 3-fraction SBRT regimen in the treatment of oligometastatic...